NeuroOne® to Report Fourth Quarter and Fiscal Year 2022 Financial Results and Provide Corporate Update on December 13
Rhea-AI Summary
NeuroOne Medical Technologies Corporation (Nasdaq: NMTC) will host a conference call on December 13, 2022, at 4:30 PM Eastern Time, to discuss its fiscal fourth quarter and full fiscal year financial results ending September 30, 2022. The call will also include a corporate update. Participants can join via a live webcast or dial in at 877-407-8293. For further information about the company, known for its innovative solutions in treating neurological disorders, visit n1mtc.com.
Positive
- Focus on minimally invasive solutions for various neurological disorders.
- Potential for improved patient outcomes and cost reductions.
Negative
- None.
News Market Reaction – NMTC
In the trading session that priced this news, NMTC gained 9.91%, reflecting a notable positive market reaction.
Data tracked by StockTitan Argus on the day of publication.
AI-generated analysis. How Rhea-AI works. Not financial advice.
EDEN PRAIRIE, Minn., Dec. 8, 2022 /PRNewswire/ -- NeuroOne Medical Technologies Corporation (Nasdaq: NMTC) ("NeuroOne" or the "Company"), a medical technology company focused on improving surgical care options and outcomes for patients suffering from neurological disorders, will host a conference call to discuss financial results for its fiscal fourth quarter and full fiscal year ended September 30, 2022, and provide a corporate update, on December 13, 2022 at 4:30 PM Eastern Time.
Conference Call and Webcast Information:
Tuesday, December 13, 2022 – 4:30 PM Eastern Time
Participant Dial-In:
877-407-8293 / +1 201-689-8349
Live Webcast:
Join here
Phone Replay:
877-660-6853 / 201-612-7415, Access ID: 13734879; available through December 27, 2022
Webcast Replay:
Available for 12 months
NeuroOne Medical Technologies Corporation is a developmental stage company committed to providing minimally invasive and hi-definition solutions for EEG recording, brain stimulation and ablation solutions for patients suffering from epilepsy, Parkinson's disease, dystonia, essential tremors, chronic pain due to failed back surgeries, and other related neurological disorders that may improve patient outcomes and reduce procedural costs. For more information, visit n1mtc.com.
View original content to download multimedia:https://www.prnewswire.com/news-releases/neuroone-to-report-fourth-quarter-and-fiscal-year-2022-financial-results-and-provide-corporate-update-on-december-13-301698053.html
SOURCE NeuroOne Medical Technologies Corporation